Utah Medical Products, Inc.UTMDNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank93
3Y CAGR+10.7%
5Y CAGR+6.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+10.7%/yr
vs +2.1%/yr prior
5Y CAGR
+6.6%/yr
Recent acceleration
Acceleration
+8.6pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $669000.00 | -17.7% |
| 2024 | $813000.00 | +45.2% |
| 2023 | $560000.00 | +13.6% |
| 2022 | $493000.00 | -6.3% |
| 2021 | $526000.00 | +8.2% |
| 2020 | $486000.00 | +0.6% |
| 2019 | $483000.00 | +6.4% |
| 2018 | $454000.00 | +1.6% |
| 2017 | $447000.00 | -5.9% |
| 2016 | $475000.00 | - |